Cinctive Capital Management LP Fulgent Genetics, Inc. Transaction History

Cinctive Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $1.06 Million - $1.38 Million	22,000 New	22,000 $1.2 Million
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $391,821 - $755,424	-7,860 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $397,322 - $539,700	-5,140 Reduced 39.54%	7,860 $791,000
Q3 2021 Nov 15, 2021	BUY	$74.87 - $110.87 $973,310 - $1.44 Million	13,000 New	13,000 $1.17 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.